1,2‐Bis­(methylsulfanyl)‐1,2‐dicarba‐closo‐dodecaborane(12)

In the title compound, 1,2‐(SCH₃)₂‐1,2‐closo‐C₂B₁₀H₁₀ or C₄H₁₆B₁₀S₂, the methylsulfanyl groups are bonded to the C atoms of the 1,2‐dicarba‐closo‐dodecaborane cage. The C_cage—C_cage distance is 1.8033 (18) Å and the S—C_cage—C_cage—S torsion angle is 1.07 (13)°. The C_cage—C_cage distance is compared with those in other 1,2‐dicarba‐closo‐dodecaborane derivatives.     

Crystal engineering with heteroboranes. II. 1,2‐Di­carboxy‐1,2‐dicarba‐closo‐dodecaborane(12) ethanol hemisolvate

The title compound, 1,2‐(COOH)₂‐1,2‐closo‐C₂B₁₀H₁₀·0.5C₂H₆O or C₄H₁₂B₁₀O₄·0.5C₂H₆O, forms a tetramer by incorporating ethanol (solvent) mol­ecules through hydrogen bonding. Two eight‐membered rings [graph set R(8)] are formed by hydrogen bonding between two carboxyl­ic acid groups, whereas two ten‐membered rings [R(10)] are formed by hydrogen bonding between two carboxyl­ic acid groups and the OH group of an ethanol mol­ecule (solvent). Two crystallographically independent tetramers are present in the crystal structure.     

1,2‐Ph2‐9‐I‐1,2‐closo‐C2B10H9

The title compound, 9‐iodo‐1,2‐di­phenyl‐1,2‐dicarba‐closo‐dodecaborane(9), C₁₄H₁₉B₁₀I, has the expected pseudo‐icosahedral cluster geometry, with a cage C—C distance of 1.724 (4) Å, comparable to that in the non‐iodinated parent. However, the twist angles, θ, of the phenyl rings are 2.1 (6) and 27.6 (5)°, the latter being unusually large.     

η5‐(3)‐1‐Methyl‐1,2‐dicarbollyl‐η5‐2′,5′‐dimethylpyrrolylcobalt(III)

In the title compound, (η⁵‐2,5‐di­methyl­pyrrolyl)[(7,8,9,10,11‐η)‐7‐methyl‐7,8‐dicarba‐nido‐undecaborato]­cobalt(III), [3‐Co{η⁵‐[2,5‐(CH₃)₂‐NC₄H₂]}‐1‐CH₃‐1,2‐C₂B₉H₁₀] or [Co(C₃H₁₃B₉)(C₆H₈N)], the Co^III atom is sandwiched between the pentagonal faces of the pyrrolyl and dicarbollide ligands, resulting in a neutral mol­ecule. The C—C distance in the dicarbollide cage is 1.649 (3) Å.     

The dimeric mixed‐ligand titana­carborane sandwich [1‐(Cp)‐1‐Ti‐2‐(Me)‐3‐(SiMe3)‐2,3‐C2B4H4]2

The title dimer, bis­[1‐cyclo­penta­dienyl‐2‐methyl‐1‐titana‐3‐tri­methylsilyl‐2,3‐dicarba‐closo‐hexaborane(6)], [Ti(C₅H₅)(C₆­H₁₆­B₄Si)]₂, reveals that the centrosymmetric mol­ecule consists of two bent‐sandwich titanacarboranes bridged by the B—H—Ti bonds. The average bond distances are Ti—B 2.445 (3), Ti—C(cage) 2.334 (2) and Ti—C(Cp) 2.376 (3) Å, and the corresponding bond angles are Cp—Ti—Cp 163.2 (1) and Cp—Ti—Cb (Cb = C₂B₃ face) 139.9 (1)°; the Ti—H separations are 2.10 (2) and 2.19 (2) Å.     

Solvent–metal interactions in bis[1,2‐dicarba‐closo‐dodecaboran(12)‐1‐yl]mercury(II) dichloromethane solvate and bis[1,12‐dicarba‐closo‐dodecaboran(12)‐1‐yl]mercury(II) tetrahydrofuran solvate

The title compounds, bis­[1,2‐dicarba‐closo‐dodecaboran(12)‐1‐yl]­mercury(II) di­chloro­methane solvate, [Hg(C₂B₁₀H₁₁)₂]·CH₂Cl₂, (I), and bis­[1,12‐dicarba‐closo‐dodecaboran(12)‐1‐yl]­mercury(II) tetra­hydro­furan solvate, [Hg(C₂B₁₀H₁₁)₂]·C₄H₈O, (II), were prepared in excellent yields using a robust synthetic procedure involving the reaction of HgCl₂ with the appropriate monoli­thiocarborane. X‐Ray analysis of the products revealed strong interactions between the Hg atoms in both complexes and the respective lattice solvent. The distances between the Hg^II centers and the Cl atoms of the dichloromethane solvent molecule in the ortho‐carborane derivative, (I), and the O atom of the tetra­hydro­furan molecule in the para‐carborane complex, (II), are shorter than the sums of the van der Waals radii for Hg and Cl (3.53 Å), and Hg and O (3.13 Å), respectively, indicating moderately strong interactions. There are two crystallographically independent mol­ecules in the asymmetric unit of both compounds, which, in each case, are related by differing relative positions of the cages.     

Two isostructural carboranes: 3‐phenyl‐1,2‐dicarba‐closo‐dodecaborane(12) and 1‐phenyl‐1,7‐dicarba‐closo‐dodecaborane(12)

Two phenyl‐substituted carboranes, 3‐phenyl‐1,2‐dicarba‐closo‐dodecaborane(12), C₈H₁₆B₁₀, (I), and 1‐phenyl‐1,7‐dicarba‐closo‐dodecaborane(12), C₈H₁₆B₁₀, (II), were found to be isostructural. Comparison of the bond angles at the ipso‐C atoms of the phenyl substituent for (I) and (II) [117.71 (3) and 118.45 (10)°, respectively] indicates that electron donation of the carborane cage for B‐ and C‐substituted carboranes is different.     

1,2:1,3‐Bis(μ‐p‐toluato‐O:O′)‐1‐(triphenylphosphine‐P)‐1‐ruthena‐closo‐undecaborane

The title compound, [(PPh₃)(p‐MeC₆H₄COO)₂RuB₁₀H₈], contains an 11‐vertex closo‐type RuB₁₀ cluster fused to two symmetric exo­poly­hedral Ru—O—C—O—B five‐membered rings. Principal distances include Ru—B 2.010 (5)–2.392 (4) Å and Ru—O 2.218 (5) and 2.222 (2) Å.     

Synthesis and characterization of three dinuclear copper(I) complexes of 1,2‐bis(diphenylphosphino)‐1,2‐dicarba‐closo‐dodecaborane

Three dinuclear copper(I) complexes, [Cu₂(µ‐Cl)₂(1,2‐(PPh₂)₂‐1,2‐C₂B₁₀H₁₀)₂]·2CH₂Cl₂ ( 1 ), [Cu₂(µ‐Br)₂(1,2‐(PPh₂)₂‐1,2‐C₂B₁₀H₁₀)₂]·2THF ( 2 ) and {Cu₂(µ‐I)₂[1,2‐(PPh₂)₂‐1,2‐C₂B₁₀H₁₀]₂} ( 3 ) have been synthesized by the reactions of CuX (X = Cl, Br and I) with the closo ligand 1,2‐(PPh₂)₂‐1,2‐C₂B₁₀H₁₀. All these complexes were characterized by elemental analysis, FT‐IR, ¹H and ¹³C NMR spectroscopy and X‐ray structure determination. Single crystal X‐ray structure determinations show that every complex contained di‐µ‐X‐bridged structure involving a crossed parallelogram plane formed by two Cu atoms and two X atoms (X = Cl, Br, I). The geometry at the Cu atom was a distorted tetrahedron, in which two positions were occupied by two P atoms of the PPh₂ groups connected to the two C atoms of carborane (Cc), and the other two resulted from two X atoms which bridged the other Cu atom at the same time. To the best of our knowledge, this is the first example of copper(I) complexes with 1,2‐diphenylphosphino‐1,2‐dicarba‐closo‐dodecaborane as ligand characterized by X‐ray diffraction. The catalytic property of the complex 3 for the amination of iodobenzene with aniline was also investigated. Copyright © 2005 John Wiley & Sons, Ltd.     

μ‐1,2‐Bis(4‐pyridyl)ethene‐κ2N:N′‐bis(tetraaqua­{4‐[2‐(4‐pyridinio)­ethenyl]pyridine‐κN}cobalt(II)) hexaaqua­cobalt(II) tetrakis(sulfate) octahydrate

The title compound, [Co₂(C₁₂H₁₁N₂)₂(C₁₂H₁₀N₂)(H₂O)₈][Co(H₂O)₆](SO₄)₄·8H₂O, consists of bis(4‐pyridyl)ethenedicobalt(II) cations, hexaaqua­cobalt cations, sulfate anions and water solvent molecules that are linked by hydrogen bonds into a network structure. In the hexaaquacobalt cation, the six water molecules are coordinated in an octahedral geometry to the Co atom, which lies on an inversion centre. The other cation is a 1,2‐bis(4‐pyridyl)ethene‐bridged centrosymmetric dimer, consisting of protonated 1,2‐bis(4‐pyridyl)­ethene cations, a bridging 1,2‐bis(4‐pyridyl)ethene ligand and tetraaqua­cobalt cations. Each Co atom is six‐coordinated by four water molecules and two N atoms from a protonated 1,2‐bis(4‐pyridyl)ethene cation and the bridging 1,2‐bis(4‐pyridyl)­ethene ligand, and the geometry around each Co atom is octahedral.     

On the short carbonyl bond in bis[μ‐1,2‐benzisothiazol‐3(2H)‐one 1,1‐dioxido‐κ2N:O]bis{[1,2‐benzisothiazol‐3(2H)‐one 1,1‐dioxido‐κN]bis(imidazole)copper(II)}

The short carbonyl bond in the title compound, [Cu₂(C₇H₄­NO₃S)₄(C₃H₄N₂)₄] [Liu, Huang, Li & Lin (1991). Acta Cryst. C 47 , 41–43], is an artifact of disorder in the iso­thia­zol‐3(2H)‐one 1,1‐dioxide part of the 1,2‐benziso­thia­zol‐3(2H)‐one entity. In the present redetermination, all bond dimensions in the centrosymmetric dinuclear mol­ecule are normal. The five‐coordinate Cu atom shows trigonal–bipyramidal coordination. Hydro­gen bonds from the imidazole donor ligand link adjacent mol­ecules into a two‐dimensional layer structure.     

The diastereoisomers methyl 5‐(S)‐[2‐(R)/(S)‐methoxycarbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methylphenyl)‐4,5‐dihydropyrazole‐3‐carboxylate

The title diastereoisomers, methyl 5‐(S)‐[2‐(S)‐methoxy­carbonyl)‐2,3,4,5‐tetra­hydro­pyrrol‐1‐yl­carbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate and methyl 5‐(S)‐[2‐(R)‐methoxycarbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxylate, both C₁₉H₂₃N₃O₅, have been studied in two crystalline forms. The first form, methyl 5‐(S)‐[2‐(S)‐methoxy­carbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methylphenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate–methyl 5‐(S)‐[2‐(R)‐methoxy­carbonyl)‐2,3,4,5‐tetra­hydro­pyrrol‐1‐yl­carbonyl]‐1‐(4‐methylphenyl)‐4,5‐dihydropyrazole‐3‐carboxylate (1/1), 2(S),5(S)‐C₁₉H₂₃N₃O₅·2(R),5(S)‐C₁₉H₂₃N₃O₅, contains both S,S and S,R isomers, while the second, methyl 5‐(S)‐[2‐(S)‐methoxycarbonyl)‐2,3,4,5‐tetrahydro­pyrrol‐1‐ylcarbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate, 2(S),5(S)‐C₁₉H₂₃N₃O₅, is the pure S,S isomer. The S,S isomers in the two structures show very similar geometries, the maximum difference being about 15° on one torsion angle. The differences between the S,S and S,R isomers, apart from those due to the inversion of one chiral centre, are more remarkable, and are partially due to a possible rotational disorder of the 2‐­(methoxycarbonyl)tetrahydropyrrole group.     

Synthesis and Characterization of 2‐Mono‐ and 1,2‐Diaminocarba‐closo‐dodecaborates M[1‐R‐2‐H2N‐closo‐CB11H10] (R=H,Ph, H2N,CyHN)

The first primary 2‐aminocarba‐closo‐dodecaborates [1‐R‐2‐H₂N‐closo‐CB₁₁H₁₀]^? (R=H ( 1 ), Ph ( 2 )) have been synthesized by insertion reactions of (Me₃Si)₂NBCl₂ into the trianions [7‐R‐7‐nido‐CB₁₀H₁₀]^3?. The difunctionalized species [1,2‐(H₂N)₂‐closo‐CB₁₁H₁₀] ( 3 ) and 1‐CyHN‐2‐H₃N‐closo‐CB₁₁H₁₀ (H‐ 4 ) have been prepared analogously from (Me₃Si)₂NBCl₂ and 7‐H₃N‐7‐nido‐CB₁₀H₁₂. In addition, the preparation of [Et₄N][1‐H₂N‐2‐Ph‐closo‐CB₁₁H₁₀] ([Et₄N]‐ 5 ) starting from PhBCl₂ and 7‐H₃N‐7‐nido‐CB₁₀H₁₂ is described. Methylation of the [1‐Ph‐2‐H₂N‐closo‐CB₁₁H₁₀]^? ion ( 2 ) to produce 1‐Ph‐2‐Me₃N‐closo‐CB₁₁H₁₀ ( 6 ) is reported. The crystal structures of [Et₄N]‐ 2 , [Et₄N]‐ 5 , and 6 were determined and the geometric parameters were compared to theoretical values derived from DFT and ab initio calculations. All new compounds were studied by NMR, IR, and Raman spectroscopy, MALDI mass spectrometry, and elemental analysis. The discussion of the experimental NMR chemical shifts and of selected vibrational band positions is supported by theoretical data. The thermal properties were investigated by differential scanning calorimetry (DSC). The pK_a values of 2‐H₃N‐closo‐CB₁₁H₁₁ (H‐ 1 ), 1‐H₃N‐closo‐CB₁₁H₁₀ (H‐ 7 ), and 1,2‐(H₃N)₂‐closo‐CB₁₁H₁₀ (H₂‐ 3 ) were determined by potentiometric titration and by NMR studies. The experimental results are compared to theoretical data (DFT and ab initio). The basicities of the aminocarba‐closo‐dodecaborates agree well with the spectroscopic and structural properties.     

Syntheses of Halogenated Polyhedral Phosphaboranes: Crystal Structure of conjuncto‐3,3′‐(closo‐1,2‐P2B4Br3)2

Co‐pyrolysis of B₂Br₄ with PBr₃ at 480 °C gave, in addition to the main product closo‐1,2‐P₂B₄Br₄, conjuncto‐3,3′‐(1,2‐P₂B₄Br₃)₂ ( 1 ) and the twelve‐vertex closo‐1,7‐P₂B₁₀Br₁₀ ( 2 ), both in low yields. X‐ray structure determination for 1 [triclinic, space‐group P1 with a = 7.220(2) Å, b = 7.232(2) Å, c = 8.5839(15) Å, α = 97.213(15)°, β = 96.81(2)°, γ = 94.07(2)° and Z = 1] confirmed that 1 adopts a structure consisting of two symmetrically boron–boron linked distorted octahedra with the bridging boron atoms in the 3,3′‐positions and the phosphorus atoms in the 1,2‐positions. The intercluster 2e/2c B–B bond length is 1.61(3) Å. The shortest boron–boron bond within the cluster framework is 1.68(2) Å located between the boron atoms antipodal to the phosphorus atoms. The icosahedral phosphaborane 2 was characterized by ¹¹B‐¹¹B COSY NMR spectroscopy showing cross peaks indicative for the isomer with the phosphorus atoms in 1,7‐positions. Both the X‐ray data of 1 and the NMR spectroscopic data of 1 and 2 give further evidence for the influence of an antipodal effect of heteroatoms to cross‐cage boron atoms and, vice versa, of an additional shielding of the phosphorus atoms caused by B‐Hal substitution at the boron positions trans to phosphorus.     

2‐(Methoxy­carbonyl)phenyl­boronic acid

The structure of the title compound, 2(CH₃OCO)C₆H₄B(OH)₂ or C₈H₉BO₄, involves two crystallographically independent conformers, A and B, in a 1:2 ratio; mol­ecules of conformer A are located on a crystallographic mirror plane. The most striking difference between the two independent mol­ecules is the opposite orientation of the methoxy­carbonyl groups, while the conformations of the boronic acid groups vary more subtly. Mol­ecules of both types are ordered to produce a specific hydrogen‐bonding network that can be inter­preted in terms of a layer lying parallel to (100). Within the layer, B mol­ecules are linked with each other by two different O—H⋯O bonds to form an infinite chain where two centrosymmetric dimeric motifs can be distinguished.     

2‐(4‐Bromophenyl)‐1,2‐dihydropyrimido[1,2‐a]benzimidazol‐4(3H)‐one and 4‐(4‐methylphenyl)‐3,4‐dihydropyrimido[1,2‐a]benzimidazol‐2(1H)‐one form hydrogen‐bonded base‐paired dimers

The title compounds, 2‐(4‐bromo­phenyl)‐1,2‐di­hydro­pyrimido­[1,2‐a]­benzimidazol‐4‐(3H)‐one, C₁₆H₁₂Br­N₃O, (IVa), and 4‐(4‐methylphenyl)‐3,4‐dihydropyrimido[1,2‐a]benzimidazol‐2‐(1H)‐one, C₁₇H₁₅N₃O, (Vb), both form R(8) centrosymmetric dimers via N—H?N hydrogen bonds. The N?N distance is 2.943 (3) Å for (IVa) and 2.8481 (16) Å for (Vb), with the corresponding N—H?N angles being 129 and 167°, respectively. However, in other respects, the supra­molecular structures of the two compounds differ. Both compounds contain different C—H?π interactions, in which the C—H?π(centroid) distances are 2.59 and 2.47 Å for (IVa) and (Vb), respectively (the latter being a short distance), with C—H?π(centroid) angles of 158 and 159°, respectively. The supramolecular structures also differ, with a short Br?O distance of 3.117 (2) Å in bromo derivative (IVa), and a C—H?O interaction with a C?O distance of 3.2561 (19) Å and a C—H?O angle of 127° in tolyl system (Vb). The di­hydro­pyrimido part of (Vb) is disordered, with a ratio of the major and minor components of 0.9:0.1. The disorder consists of two non‐interchangeable envelope conformers, each with an equatorial tolyl group and an axial methine H atom.     

Three structures containing (E)‐1,2‐bis­(benzimidazol‐2‐yl)ethene groups

Two of the title compounds, namely (E)‐1,2‐bis­(1‐methyl­benzimidazol‐2‐yl)ethene, C₁₈H₁₆N₄, (Ib), and (E)‐1,2‐bis­(1‐ethyl­benzimidazol‐2‐yl)ethene, C₂₀H₂₀N₄, (Ic), consist of centrosymmetric trans‐bis­(1‐alkyl­benzimidazol‐2‐yl)ethene mol­ecules, while 3‐eth­yl‐2‐[(E)‐2‐(1‐ethyl­benzimidazol‐2‐yl)­ethen­yl]benzimidazol‐1‐ium perchlorate, C₂₀H₂₁N₄⁺·ClO₄⁻, (II), contains the monoprotonated analogue of compound (Ic). In the three structures, the benzimidazole and benzimidazolium moieties are essentially planar; the geometric parameters for the ethene linkages and their bonds to the aromatic groups are consistent with double and single bonds, respectively, implying little, if any, conjugation of the central C=C bonds with the nitro­gen‐containing rings. The C—N bond lengths in the N=C—N part of the benzimidazole groups differ and are consistent with localized imine C=N and amine C—N linkages in (Ib) and (Ic); in contrast, the corresponding distances in the benzimidazolium cation are equal in (II), consistent with electron delocalization resulting from protonation of the amine N atom. Crystals of (Ib) and (Ic) contain columns of parallel mol­ecules, which are linked by edge‐over‐edge C—H⋯π overlap. The columns are linked to one another by C—H⋯π inter­actions and, in the case of (Ib), C—H⋯N hydrogen bonds. Crystals of (II) contain layers of monocations linked by π–π inter­actions and separated by both perchlorate anions and the protruding eth­yl groups; the cations and anions are linked by N—H⋯O hydrogen bonds.     

cis‐[1,2‐Bis(diisopropylphosphino‐κP)‐1,2‐dicarba‐closo‐dodecaborane]dichloroplatinum(II) dichloromethane hemisolvate

The asymmetric unit of the title complex, [PtCl₂(C₁₄H₃₈B₁₀P₂)]·0.5CH₂Cl₂ or cis‐[PtCl₂{1,2‐(PⁱPr₂)₂‐1,2‐C₂B₁₀H₁₀}]·0.5CH₂Cl₂, contains one disordered solvent mol­ecule and two mol­ecules of the complex, in which each Pt^II atom displays slightly distorted square‐planar coordination geometry. The P atoms connected to the cage C atoms are coordinated to the Pt^II atom. The Pt—P distances vary slightly [2.215 (3) and 2.235 (4) Å] and the Pt—Cl distances are equal [2.348 (3) and 2.353 (5) Å].     

6‐(3,4‐Di­fluoro­benzoyl)‐3‐[2‐(4‐pyridyl)­ethyl]‐1,3‐benzo­thia­zol‐2(3H)‐one

A new type of benzo­thia­zolinone derivative with potential pharmacological activity, viz. 6‐(3,4‐di­fluoro­benzoyl)‐3‐[2‐(4‐pyridyl)­ethyl]‐1,3‐benzo­thia­zol‐2(3H)‐one, C₂₁H₁₄F₂N₂O₂S, has been prepared and studied by NMR, IR and single‐crystal X‐ray diffraction techniques. The mol­ecule is not planar, the pyridine and di­fluoro­benzene moieties being located above and below the benzo­thia­zole ring system. The carbonyl O atoms are involved in an intramolecular hydrogen‐bond‐type interaction.     

Synthesis,characterization, X‐ray crystal structure and in vitro antitumour activity of sodium bis(2‐(3′,6′,9′‐trioxadecyl)‐1,2‐dicarba‐closo‐dodecaborane‐1‐carboxylato)triphenylstannate

Sodium bis[2‐(3′,6′,9′‐trioxadecyl)‐1,2‐dicarba‐closo‐dodecaborane‐1‐carboxylato]triphenylstannate, [(CH₃OCH₂CH₂OCH₂CH₂OCH₂CH₂)‐1,2‐C₂B₁₀H₁₀‐9‐COO)₂SnPh₃]^? Na⁺, compound 1, was synthesized by the 1:1 condensation of triphenyltin(IV) hydroxide with 2‐(3′,6′,9′‐trioxadecyl)‐1,2‐dicarba‐closo‐dodecaborane‐1‐carboxylic acid and crystallized in the presence of sodium bicarbonate. Its structure was determined by spectroscopy, elemental analysis and X‐ray diffraction. The structure of 1 consists of trigonal bipyramidal [Sn(Ph)₃(L)₂]^? anions and Na⁺ cations coordinated by oxygen atoms of polyoxaalkyl chains of different stannate anions, forming cation–anion chains elongated along the c axis. Compound 1 is significantly more active in vitro against seven tumour cell lines of human origin than 5‐fluorouracil, cis‐platin, carboplatin, and previously reported organotin carboranecarboxylates, but is less active than organotin polyoxaalkylcarboxylates. Copyright © 2004 John Wiley & Sons, Ltd.